Hong Kong SAR China · Series E startup
4 rounds we have observed, with the 28 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$392Mraised across 4 rounds since 2014, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Value Partners GroupLead
Sequoia Capital
Qiming Venture Partners
HSG
B Capital
Warburg Pincus
Eli LillyReported by Firms' own news pages and 1 other
Warburg PincusLeadQiming Venture PartnersB Capital
OrbiMed
Eight Roads Ventures
Deerfield
Sinovation Ventures
Pavilion Capital
Bold Capital Partners
Mirae Asset Capital
Maison Capital
Formic Ventures
Sage PartnersReported by Firms' own news pages and 1 other
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Qiming Venture PartnersLBaidu VenturesWarburg PincusLB CapitalEight Roads VenturesSinovation VenturesLilly Asia VenturesPavilion CapitalBold Capital PartnersValue Partners GroupLMissing a round, or an investor who was in one? Tell us.
Insilico Medicine's investors include Qiming Venture Partners, Baidu Ventures, Warburg Pincus, B Capital and Eight Roads Ventures, and 23 more on record. Value Partners Group led its latest round.
Insilico Medicine has raised $392M across 4 rounds since 2014. One round did not disclose an amount, so the total is a floor.
Insilico Medicine's most recent round was a Series E of $100M in Mar 2025, led by Value Partners Group.
Insilico Medicine's largest round on record is $255M (Series C), in Jun 2021, led by Warburg Pincus.
Insilico Medicine's first round on record, in Apr 2014, was backed by Deep Knowledge Ventures.
Insilico Medicine's latest named round is a Series E, in Mar 2025.
Insilico Medicine is based in Hong Kong SAR China.
Qiming Venture Partners led the Series B in 2019; Warburg Pincus led the Series C in 2021; Value Partners Group led the Series E in 2025.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Hong Kong SAR China · 
